Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2026-03-20–present
Junyoung Yu
Equibles does not estimate personal net worth.
Get an email with a short summary when Apimeds Pharmaceuticals US, Inc. publishes a filing, an earnings call transcript or a press release.
Get APUS alertsAbout Junyoung Yu
Junyoung Yu is recorded as Board Member at Apimeds Pharmaceuticals US, Inc. (APUS) since March 20, 2026. Apimeds Pharmaceuticals US, Inc. reported in an 8-K filed March 25, 2026 that Junyoung Yu was appointed Secretary, effective March 20, 2026. Apimeds Pharmaceuticals US, Inc. reported in an 8-K filed March 25, 2026 that Junyoung Yu was appointed Director, effective March 20, 2026. Apimeds Pharmaceuticals US, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Apimeds Pharmaceuticals US, Inc. includes Sungjoon Chae (CEO and Board Member), Vin Menon (CEO and Board Member), Youngjik Cho (CEO, Chairman and Board Member) and 3 others.
“Mr. Cho was appointed as the new Chief Executive Officer of the Company and Mr. Yu as Secretary of the Company, effective immediately.”
“Pursuant to the Written Consent, the Majority Stockholders also appointed Mr. Youngjik Cho, Mr. Minguk Ji and Mr. Junyoung Yu to serve as Directors of the Company (the "Board"), effective immediately, to fill three of the resulting vacancies.”
Affiliation history
-
Current
2026-03-20–present
-
Current
2026-03-20–present
Company network
Leadership on record at Apimeds Pharmaceuticals US, Inc.
- Sungjoon Chae CEO, Board Member
- Vin Menon CEO, Board Member
- Youngjik Cho CEO, Chairman, Board Member
- Eric Sherb CFO
- Amir Dossal Board Member
- Minguk Ji Board Member